National Prescription Drug Take-Back Day Is April 27

April 23, 2019

This year’s annual National Prescription Drug Take-Back Day, hosted by the Drug Enforcement Administration (DEA), is April 27 from 10 a.m. to 2 p.m.  read more

SBA and SCORE Offer Online Conference for Small Business Owners

April 22, 2019

The U.S. Small Business Administration and SCORE will host a two-day virtual conference during National Small Business Week May 7–8.  read more

NCPA Requests Survey, Offers Benchmark Report

April 18, 2019

The NCPA is offering a free pharmacy benchmarking report customized for pharmacies that complete NCPA’s annual pharmacy financial benchmarking survey.  read more

Half of Patients Have Suboptimal Response to Statins

April 17, 2019

More than half of patients on statin therapy don’t see optimal improvement within two years, and even experience increased risk of future cardiovascular disease, according to a study published online April 15 in Heart.  read more

Newly Approved Osteoporosis Drug Increases Bone Density

April 16, 2019

The FDA approved an osteoporosis drug on April 16 with a novel treatment approach, according to The New York Times.   read more

Registration Open for National Small Business Week Virtual Conference

April 15, 2019

The U.S. Small Business Administration and SCORE will host a FREE 2-Day Virtual Conference during National Small Business Week.   read more

Utah Allows Pharmacists to Dispense Contraceptives Without Patient Prescription

April 12, 2019

The executive director of the Utah Department of Health signed a statewide standing order that allows women to purchase hormonal contraception without needing a prescription.  read more

FDA Warns Against Using Pre-Owned Test Strips

April 10, 2019

The FDA on April 9 issued a safety communication alerting patients and health care professionals about the risks of using test strips from a previous owner or test strips not authorized for sale in the U.S. These strips may cause infection or lead to inaccurate test results, which can cause serious harm, including death, the agency said.   read more

FDA Warns Against False Pharmacogenetic Claims

April 9, 2019

The FDA issued a warning to Inova Genomics Laboratory for the illegal marketing of pharmacogenetic tests for predicting medication response to antidepressants, opioids, cancer therapy, anesthesia, and diabetes treatments.  read more

FDA Outlines 2019 Compounding Priorities

April 4, 2019

The U.S. Food and Drug Administration (FDA) on April 3 released a statement outlining its compounding priorities for 2019.   read more